GB9922709D0 - Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases - Google Patents
Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseasesInfo
- Publication number
- GB9922709D0 GB9922709D0 GBGB9922709.2A GB9922709A GB9922709D0 GB 9922709 D0 GB9922709 D0 GB 9922709D0 GB 9922709 A GB9922709 A GB 9922709A GB 9922709 D0 GB9922709 D0 GB 9922709D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- biarylbutyric
- substituted
- treatment
- acid derivatives
- respiratory diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (17)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9922709.2A GB9922709D0 (en) | 1999-09-24 | 1999-09-24 | Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases |
AU19825/00A AU1982500A (en) | 1998-12-30 | 1999-12-20 | Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases |
CA002356053A CA2356053A1 (en) | 1998-12-30 | 1999-12-20 | Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases |
KR1020017008314A KR20010101325A (en) | 1998-12-30 | 1999-12-20 | Use of Substituted 4-Biarylbutyric and 5-Biarylpentanoic Acid Derivatives as Matrix Metalloprotease Inhibitors for the Treatment of Respiratory Diseases |
BR9916669-0A BR9916669A (en) | 1998-12-30 | 1999-12-20 | Use of derivatives of substituted 4-biarylbutyric and 5-biarylpentanoic acids as matrix metalloprotease inhibitors for the treatment of respiratory diseases |
PCT/EP1999/010110 WO2000040539A1 (en) | 1998-12-30 | 1999-12-20 | Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases |
US09/869,668 US6900194B1 (en) | 1998-12-30 | 1999-12-20 | Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases |
EP99963582A EP1140768A1 (en) | 1998-12-30 | 1999-12-20 | Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases |
IL14359499A IL143594A0 (en) | 1998-12-30 | 1999-12-20 | Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases |
JP2000592250A JP2002534404A (en) | 1998-12-30 | 1999-12-20 | Use of substituted 4-biarylbutyric acid and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases |
CN99816404A CN1337932A (en) | 1998-12-30 | 1999-12-20 | Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treamtent of respiratory diseases |
TR2001/01970T TR200101970T2 (en) | 1998-12-30 | 1999-12-20 | The use of substituted 4-biarylbutyric and 5-biarylpentanoic acid t revs as matrix metalloprotease inhibitors in the treatment of respiratory diseases |
ARP990106795A AR035472A1 (en) | 1998-12-30 | 1999-12-28 | USE OF 4-BIARILBUTIRIC AND 5-BIARILPENTANOIC ACID DERIVATIVES REPLACED AS INHIBITORS OF MATRIX METALOPROTEASE FOR THE TREATMENT OF RESPIRATORY DISEASES, COMPOUNDS AND COMPOSITIONS THAT INCLUDE THEM |
PE1999001333A PE20001339A1 (en) | 1998-12-30 | 1999-12-28 | USE OF DERIVATIVES OF 4-BIARYLBUTYRIC ACID AND 5-BIARYLPENTANOIC SUBSTITUTE AS INHIBITORS OF MATRIX METALOPROTEASE FOR THE TREATMENT OF RESPIRATORY DISEASES |
UY25888A UY25888A1 (en) | 1998-12-30 | 1999-12-30 | DERIVATIVES OF 4-BIARILBUTIRICO AND 5-BIARILPENTANOICO ACID SUBSTITUTES USEFUL AS MATRIX METALPROTEASE INHIBITORS FOR THE TREATMENT OF RESPIRATORY DISEASES |
CO99081622A CO5261506A1 (en) | 1998-12-30 | 1999-12-30 | USE OF 4-BIARILBUTIRICO AND 5-BIARILPENTANOICO DERIVATIVES REPLACED AS INHIBITORS OF MATRIX METALOPROTEASE FOR THE TREATMENT OF RESPIRATORY DISEASES |
HK02105193.2A HK1043981A1 (en) | 1998-12-30 | 2002-07-12 | Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9922709.2A GB9922709D0 (en) | 1999-09-24 | 1999-09-24 | Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
GB9922709D0 true GB9922709D0 (en) | 1999-11-24 |
Family
ID=10861598
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB9922709.2A Ceased GB9922709D0 (en) | 1998-12-30 | 1999-09-24 | Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB9922709D0 (en) |
-
1999
- 1999-09-24 GB GBGB9922709.2A patent/GB9922709D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200707934B (en) | Thereapeutic formulations for the treatment of beta-amyloid related diseases | |
HUP0003863A3 (en) | Alpha-sulfonylamino hidroxamic acid inhibitors of matrix metalloproteinases for the treatment of peripheral or central nervous system disorders | |
IL143594A0 (en) | Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases | |
IL167250A (en) | Chirale oxazole-arylpropionic acid derivatives, compositions comprising thereof and their use in the preparation of medicaments for the treatment of ppar alpha/ ppar gamma agonists-modulated diseases | |
PT1487828E (en) | Morpholinyl-urea derivatives for use of the treatment of inflamatory diseases | |
AU2002220735A1 (en) | Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain | |
HUP0303041A3 (en) | Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain | |
HRP20020893A2 (en) | Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases | |
HK1044536A1 (en) | Crystals of an oxyiminoalkanoic acid derivative and their use as antidiabetics | |
HUP0104963A3 (en) | Compositions for the treatment of skin diseases | |
GB9929497D0 (en) | Improved amino acid mixtures for the treatment and/or management of certain diseases | |
HK1057332A1 (en) | Use of 3-benzoylphenylacetic acid derivatives for the treatment of retinal disorders | |
HK1045260B (en) | Heteroatom-interrupted analogs of 15-hydroxyeicosatetraenoic acid and methods of use | |
GB0111594D0 (en) | Pipecolnic acid derivatives method of manufacturing the same and therapeutic agents containing these compounds | |
AU9545701A (en) | Use of carp inhibitors for the treatment of heart diseases | |
AU7653600A (en) | Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of multiple sclerosis | |
EP1150669A4 (en) | L-arginine based formulations for treating diseases and methods of using same | |
HUP0203270A3 (en) | Hydroxamic acid derivative as inhibitor of the formation of human cd23, process for its preparation and pharmaceutical compositions containing the same | |
GB9922709D0 (en) | Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases | |
AU2900100A (en) | Methods for inhibiting cathepsin k activity for the treatment of diseases related to bone loss | |
GB9828845D0 (en) | Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases | |
AU2001273801A1 (en) | Dehydrobaimuxinol derivatives use as medicaments for treating or preventing regressive diseases of brain | |
AU4101900A (en) | Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of cerebral diseases | |
HUP0301971A3 (en) | Uses of thaliporphine or its derivatives for producing pharmaceutical compositions suitable for treating cardiac diseases and the compounds | |
AU2908501A (en) | Combination therapy for the treatment of inflammatory and respiratory diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |